TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 

Pleural Effusion

Pleural Effusion: Excerpt from The 5-Minute Pediatric Consult

Richard M. Kravitz, MD

Pleural Effusion - BASICS

Pleural Effusion - description

Accumulation of fluid in the pleural cavity

Pleural Effusion - epidemiology

  • Dependent on underlying cause
  • Pneumonia (most common cause):
    • Staphylococcus aureus (increasing incidence of methicillin-resistant species)
    • Streptococcus pneumoniae (increasing incidence of penicillin-resistant species)
    • Hemophilus influenzae (decreasing incidence since introduction of Hemophilus influenzae type B [HiB] vaccine)
    • No identified organisms (all cultures sterile)
  • Congenital heart disease
  • Malignancy

Pleural Effusion - pathophysiology

  • Dependent on the underlying disease
  • 2 types of pleural effusion:
    • Transudate: Mechanical forces of hydrostatic and oncotic pressures are altered, favoring liquid filtration.
    • Exudate: Damage to the pleural surface occurs that alters its ability to filter pleural fluid; lymphatic drainage is diminished.
  • Stages associated with parapneumonic effusions (infectious exudates):
    • Exudative stage:
      • Free-flowing fluid
      • Pleural fluid glucose, protein, lactate dehydrogenase (LDH) level, and pH are normal.
    • Fibrinolytic stage:
      • Loculations are forming.
      • Increase in fibrin, polymorphonuclear leukocytes, and bacterial invasion of pleural cavity are occurring.
      • Pleural fluid glucose and pH falls while protein and LDH levels increase.
    • Organizing stage (empyema):
      • Fibroblasts grow.
      • Pleural peal forms.
      • Pleural fluid parameters worsen.

Pleural Effusion - etiology

  • Normally 1–15 mL of fluid in the pleural space
  • Alterations in the flow and/or absorption of this fluid lead to its accumulation.
  • Mechanisms that influence this flow of fluid:
    • Increased capillary hydrostatic pressure (i.e., CHF, overhydration)
    • Decreased pleural space hydrostatic pressure (i.e., after thoracentesis, atelectasis)
    • Decreased plasma oncotic pressure (i.e., hypoalbuminemia, nephrosis)
    • Increased capillary permeability (i.e., infection, toxins, connective tissue diseases, malignancy)
    • Impaired lymphatic drainage from the pleural space (i.e., disruption of the thoracic duct)
    • Passage of fluid from the peritoneal cavity through the diaphragm to the pleural space (i.e., hepatic cirrhosis with ascites)

Pleural Effusion - DIAGNOSIS

Pleural Effusion - signs & symptoms

Pleural Effusion - history

  • Underlying disease determines most systemic symptoms.
  • Patient may be asymptomatic until the amount of fluid is large enough to cause cardiorespiratory distress.
  • Dyspnea and cough are associated with large effusions.
  • Fever (if infectious etiology)
  • Pleuritic pain (pneumonia may cause irritation of the parietal pleura causing pleural pain; as the effusion increases and separates the pleural membrane, the pain may disappear)

Pleural Effusion - physical exam

  • Decreased thoracic wall excursion on the ipsilateral side
  • Fullness of intercostal spaces on the ipsilateral side
  • Trachea and cardiac apex displaced toward the contralateral side (may produce a mediastinal shift that can reduce venous return and compromise the cardiac output)
  • Dull or flat percussion on the ipsilateral side (suggesting the presence of consolidation of pleural effusion)
  • Decreased tactile and vocal fremitus
  • Decreased whispering pectoriloquy
  • Pleural rub during early phase (may resolve as fluid accumulates in the pleural space)
  • Decreased breath sounds

Pleural Effusion - tests

  • Cytologic examination of pleural fluid:
    • Fresh and heparinized specimen should be refrigerated at 4°C (39.2°F) until it can be processed.
    • Fixatives should not be added.
  • Pleural fluid parameters to be routinely measured include:
    • pH
    • LDH
    • Protein
    • Glucose
      • Note: Glucose of <40 mg/dL suggests a parapneumonic, tuberculosis, malignant, or rheumatic etiology to the effusion.

Pleural Effusion - lab

Serology values to follow the degree of inflammation and the response to therapy:

  • Erythrocyte sedimentation rate (ESR)
  • C-reactive protein (CRP)

Pleural Effusion - imaging

  • Chest radiograph:
    • Anteroposterior projection can show >400 mL of pleural fluid.
    • Lateral projection can show <200 mL of pleural fluid.
    • Lateral decubitus film to evaluate for free-flowing pleural fluid can show as little as 50 mL of pleural fluid.
  • Ultrasound:
    • Reveals small (3–5 mL) loculated collections of pleural fluid
    • Useful as a guide for thoracentesis
    • Aids in distinguishing between pleural thickening and pleural effusion
  • CT scan:
    • Clearly reveals effusions/empyemas, abscess, or pulmonary consolidations
    • Useful for defining the extent of loculated effusions

Pleural Effusion - diag proced-surgery

  • Thoracentesis:
    • Indicated whenever cause is unclear or effusion causes symptoms, e.g., prolonged fever or respiratory distress
  • Pleural biopsy:
    • If thoracentesis is nondiagnostic
    • Most useful for diseases that cause extensive involvement of the pleura (i.e., tuberculosis, malignancies)
    • Confirms neoplastic involvement in 40–70% of cases

Pleural Effusion - differencial diagnosis

  • Transudate:
    • Cardiovascular:
      • CHF
      • Constrictive pericarditis
    • Nephrotic syndrome with hypoalbuminemia
    • Cirrhosis
    • Atelectasis
  • Exudate:
    • Infection:
      • Bacterial effusions (S. aureus is most common organism)
      • Tuberculous effusion
      • Viral effusions (adenovirus, influenza)
      • Fungal effusions: Most not associated with effusions; Nocardia and Actinomyces are most commonly seen.
      • Parasitic effusions
    • Neoplasm: Seen mostly in leukemia and lymphoma; uncommon in children
    • Connective tissue disease:
      • Rheumatoid arthritis
      • Systemic lupus erythematosus
      • Wegener granulomatosis
    • Pulmonary embolus
    • Intra-abdominal disease:
      • Subdiaphragmatic abscess
      • Pancreatitis
    • Sarcoidosis
    • Esophageal rupture
    • Hemothorax
    • Chylothorax
    • Drugs
    • Chemical injury
    • Postirradiation effusion

Pleural Effusion - TREATMENT

Pleural Effusion - general measures

  • Supportive measures:
    • Maintain adequate:
      • Oxygenation
      • Fluid status
      • Nutritional balance
    • Antipyretic agents when febrile
    • Pain control
  • Treat the underlying disease:
    • Antibiotics for infections
    • Cardiac medications for congestive heart failure
    • Chemotherapeutic agents for malignancies
    • Anti-inflammatory agents (i.e., steroids) for connective tissue diseases
    • Medium-chain triglycerides and low-fat diet for chylothorax
  • Effective drainage of pleural fluid:
    • Thoracentesis
    • Chest tube drainage
    • Surgical drainage
  • Duration of chest tube drainage:
    • Discontinue when patient is asymptomatic (afebrile, no distress) and drainage <50 mL/h
    • Thick, loculated empyema requires prolonged drainage (and possibly a video-assisted thoracic surgery [VATS] procedure if effusion not improving).

Pleural Effusion - diet

When the effusion is a chylothorax:

  • Medium-chain triglycerides
  • Nutritional replacement
  • At least 4–5 weeks on this regimen

Pleural Effusion - special therapy

  • Thoracentesis:
    • For diagnosis purposes:
      • To distinguish between a transudate and an exudate
      • For culture material (if infection is suspected)
      • For cytology (if malignancy is suspected)
    • For relief of dyspnea or cardiorespiratory distress
  • Chest tube thoracostomy:
    • Reduce reaccumulation of fluid.
    • Drain parapneumonic effusion (before loculations develop which will prevent fluid drainage).
  • Intrapleural fibrinolytics:
    • Adjunct to aid in drainage of complicated (i.e., multiloculated empyema) pleural effusions
    • Streptokinase and urokinase are agents of choice.

Pleural Effusion - medication

Antibiotics:

  • Used when effusion is caused by a bacterial infection
  • Specific antibiotics dictated by organism identified
  • If effusion is sterile, broad-spectrum antibiotics are indicated to cover for the usually seen organisms.
  • Clinical improvement usually begins within 48–72 hours of therapy.
  • Continue IV antibiotics until afebrile.
  • Complete remainder of therapy on oral antibiotics
  • Duration of antibiotic therapy is dependent on the infectious organism and the degree of illness.
    • Total duration is controversial.
    • Usually 2–4 weeks minimum of total IV and PO

Pleural Effusion - surgery

  • VATS:
    • Alternative to more invasive procedures (e.g., open thoracotomy/decortication)
    • Débridement through pleural visualization and lysis of adhesions/loculations
    • Useful when:
      • Initial drainage is delayed
      • Loculations prevent adequate drainage by chest tube alone
      • Patient is failing more conservative therapy
  • Pleurectomy:
    • Chylothorax
    • Malignant effusions
  • Pleurodesis:
    • For recurrent effusions
    • Chemical agents frequently used include talc, tetracycline, doxycycline, and quinacrine.
    • Surgical methods include:
      • Mechanical abrasion
      • Pleurectomy via VATS
      • Open thoracotomy route
    • In cases of malignant effusion:
      • Sclerosing procedures are usually ineffective.
      • Chest tube drainage can create a pneumothorax because the lung is incarcerated by the tumor.

Pleural Effusion - FOLLOW UP

  • Clinical improvement usually within 1–2 weeks
  • With empyemas, the patient may have fever spikes for up to 2–3 weeks after improvement is noted.

Pleural Effusion - prognosis

Dependent on underlying disease process:

  • Properly treated infectious cause: Excellent prognosis
  • Malignancy: Poor prognosis

Pleural Effusion - complications

  • Hypoxia
  • Respiratory distress
  • Persistent fevers
  • Decreased cardiac function
  • Malnutrition (seen in chylothorax)
  • Shock (secondary to blood loss in cases of hemothorax)
  • Trapped lung

Pleural Effusion - bibliography

  1. Alkrinawi S, Chernick V. Pleural infection in children. Semin Respir Infect. 1996;11:148–154.
  2. Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase vs. urokinase in the treatment of complicated parapneumonic effusions: A prospective, double blind study. Am J Respir Crit Care Med. 1997;155:291–295.
  3. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children. Pediatr Infect Dis. 2003;22:499–504.
  4. de Benedictis FM, De Giorgi G, Niccoli A, et al. Treatment of complicated pleural effusion with intracavitary urokinase in children. Pediatr Pulmonol. 2000;29:438–442.
  5. Doski JJ, Lou D, Hicks BA, et al. Management of parapneumonic collections in infants and children. J Pediatr Surg. 2000;35:265–268; discussion 269–270.
  6. Givan DC, Eigen H. Common pleural effusions in children. Clin Chest Med. 1998;19:363–371.
  7. Heffner JE. Infection of the pleural space. Clin Chest Med. 1999;20:607–622.
  8. Heffner JE. Discriminating between transudates and exudates. Clin Chest Med. 2006;27:241–252.
  9. Kornecki A, Sivan Y. Treatment of loculated pleural effusion with intrapleural urokinase in children. J Pediatr Surg. 1997;32:1473–1475.
  10. Light RW. The undiagnosed pleural effusion. Clin Chest Med. 2006;27:309–319.
  11. Merino JM, Carpintero I, Alvarez T, et al. Tuberculous pleural effusion in children. Chest. 1999;115:26–30.
  12. Montgomery M, Sigalet D. Air and liquid in the pleural space. In: Chernick V, ed. Kendig’s Disorders of the Respiratory Tract in Children. Philadelphia: WB Saunders; 2006:368–387.
  13. Ramnath RR, Heller RM, Ben-Ami T, et al. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia. Pediatrics. 1998;101(1 Part 1):68–71.
  14. Rahman NM, Chapman SJ, Davies RJ. The approach to the patient with a parapneumonic effusion. Clin Chest Med. 2006;27:253–266.

Pleural Effusion - CODES

Pleural Effusion - icd9

511.9 Pleural effusion

Pleural Effusion - FAQ

  • Q: When will the chest radiograph findings become normal?
  • A: They may take up to 6 months (or longer) to return to normal appearance.
  • Q: When will the pulmonary function tests normalize?
  • A: Dependent on extent of effusion, they may take up to 6–12 months.
>>>

Book Source Details

  • Book Title: The 5-Minute Pediatric Consult
  • Author(s): M. William Schwartz MD; et al.
  • Year of Publication: 2008
  • Copyright Details: The 5-Minute Pediatric Consult, Copyright © 2008 Lippincott Williams & Wilkins.

More About Pleural effusion

More Medical Textbooks Online about Pleural effusion

Review other book chapters online related to Pleural effusion:

Medical Books Excerpts
  • Pleural Effusion
  • "The 10-Minute Diagnosis Manual: Symptoms and Signs in the Time-Limited Encounter" (2000)
 

Copyright notice for book excerpts: Copyright © 2008 Lippincott Williams & Wilkins. All rights reserved.




More About This Book:
Title: The 5-Minute Pediatric Consult
Authors: M. William Schwartz MD; et al.
Publisher: Lippincott Williams & Wilkins
Copyright: 2008
ISBN: 0-7817-7577-9

 » Next page: Surveys relating to Pleural effusion

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise